Allergan is recalling one lot of birth-control pills — or 170,000 packs — because the first four pills in each 28-pill pack are inactive, placing women at risk of pregnancy.

One lot of Taytulla physician sample packs (marked lot #5620706 Exp. May 2019) contained the out-of-order pills, the company said. It learned about the error from a doctor who reported it.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • In the current hyper-partisan environment, I can only suggest that Allergan needs to find if it has “a hardened Republican in QA” who also opposes the concept of birth control. That would explain, “this little mix-up.”

    Justify, absolutely not but it’s a nifty conspiracy theory……

Your daily dose of news in health and medicine

Privacy Policy